NASDAQ: AAPGAscentage Pharma Group International Stock Ownership - Who owns Ascentage Pharma Group International?
Insider buying vs selling
Have Ascentage Pharma Group International insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when AAPG insiders and whales buy or sell their stock.
AAPG Shareholders
What type of owners hold Ascentage Pharma Group International stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Yifan Zhai | 10.06% | 37,553,770 | $859.04M | Insider |
| Dajun Yang | 10.06% | 37,553,770 | $859.04M | Insider |
| Shaomeng Wang | 2.69% | 10,053,943 | $229.98M | Insider |
| Thomas J. Knapp | 0.10% | 362,444 | $8.29M | Insider |
| Simon Dazhong Lu | 0.01% | 41,457 | $948.33k | Insider |
| Marc E. Lippman | 0.01% | 21,174 | $484.36k | Insider |
| Point72 Asset Management LP | 0.00% | 16,726 | $382.61k | Institution |
| Xy Capital Ltd | 0.00% | 13,628 | $311.74k | Institution |
| David Sidransky | 0.00% | 10,641 | $243.41k | Insider |
| Citadel Advisors LLC | 0.00% | 9,737 | $222.73k | Institution |
AAPG vs Biotech Stocks
Ascentage Pharma Group International Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.